Phapros Tbk PT
IDX:PEHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hypoport SE
XETRA:HYQ
|
DE |
Phapros Tbk PT
Cash from Operating Activities
Phapros Tbk PT
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Phapros Tbk PT
IDX:PEHA
|
Cash from Operating Activities
Rp123.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Cash from Operating Activities
Rp1.5T
|
CAGR 3-Years
45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Cash from Operating Activities
Rp3.3T
|
CAGR 3-Years
37%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Cash from Operating Activities
Rp896.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Cash from Operating Activities
-Rp364.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Cash from Operating Activities
Rp234.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
3%
|
|
Phapros Tbk PT
Glance View
PT Phapros Tbk is a pharmaceutical company, which engages in the production and marketing of pharmaceutical products. The company is headquartered in Jakarta Selatan, Dki Jakarta and currently employs 1,485 full-time employees. The company went IPO on 2018-12-26. The firm's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, DEXTROFEN S SYRUP 60ml, Diafac XR, Diafac 500 mg 10 tablets, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, Pehavask 5 & 10, Spirolactone 25 & 100, Dios, anemone, Pladel, and others. The firm also operates calibration laboratory. The company offers medicines for cardiovascular & hematopoietic, gastrointestinal & hepatobiliary, hormone Genito, urinary endocrine & metabolic, vitamins & minerals nutrition, dermatology, local anesthesia, immune & allergy, and others.
See Also
What is Phapros Tbk PT's Cash from Operating Activities?
Cash from Operating Activities
123.8B
IDR
Based on the financial report for Dec 31, 2025, Phapros Tbk PT's Cash from Operating Activities amounts to 123.8B IDR.
What is Phapros Tbk PT's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-14%
Over the last year, the Cash from Operating Activities growth was -12%. The average annual Cash from Operating Activities growth rates for Phapros Tbk PT have been -11% over the past three years , -14% over the past five years .
